http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2869531-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a51de47b365cf6f054cf2c9837d73268
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0412
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-303
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00
filingDate 2004-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26ad70642237279674ca988344ca7ca9
publicationDate 2005-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2869531-A1
titleOfInvention OCULAR IONTOPHORESIS DEVICE REDUCING IRRITATION
abstract The invention relates to an ocular iontophoresis device, for the delivery of active principles, comprising a reservoir of active principles able to come to be positioned on the eye, active principles in solution in the reservoir, an active electrode disposed in the reservoir, and a passive electrode, characterized in that it comprises active principles dissolved in non-saline water, in that the solution it contains has a pH of between 6.5 and 8.5, in that the active ingredients have a pKa of between about 5.5 and about 9.5 and are adjunct-bound, such as dendrimers, polymers, nanoparticles, microspheres, liposomes or emulsions and have a higher valence ionic form or equal to 1.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2898922-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9238131-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8099162-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10478333-B2
priorityDate 2004-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0240189-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6001088-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5905
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID140399134
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414865299
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12358601
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447875226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426590015
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414880847
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9782
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489674
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553275
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31307
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505112
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16923
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504692
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9400
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65389
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398740

Total number of triples: 48.